162 related articles for article (PubMed ID: 36757800)
1. IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy.
Tunalı G; Rúbies Bedós M; Nagarajan D; Fridh P; Papakyriacou I; Mao Y
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36757800
[TBL] [Abstract][Full Text] [Related]
2. MYD88, IRAK3 and Rheumatoid Arthritis pathogenesis: Analysis of differential gene expression in CD14 + monocytes and the inflammatory cytokine levels.
Gomes da Silva IIF; Barbosa AD; Souto FO; Maia MMD; Crovella S; Souza PRE; Sandrin-Garcia P
Immunobiology; 2021 Nov; 226(6):152152. PubMed ID: 34735922
[TBL] [Abstract][Full Text] [Related]
3. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P
PLoS One; 2013; 8(4):e62253. PubMed ID: 23620818
[TBL] [Abstract][Full Text] [Related]
4. Targeting IRAK3 for Degradation to Enhance IL-12 Pro-inflammatory Cytokine Production.
Rowley A; Brown BS; Stofega M; Hoh H; Mathew R; Marin V; Ding RX; McClure RA; Bittencourt FM; Chen J; Gururaja T; Kinoshita T; Wang X; Rivkin A; Woller KR
ACS Chem Biol; 2022 Jun; 17(6):1315-1320. PubMed ID: 35580266
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
[TBL] [Abstract][Full Text] [Related]
6. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.
Chen EP; Markosyan N; Connolly E; Lawson JA; Li X; Grant GR; Grosser T; FitzGerald GA; Smyth EM
Carcinogenesis; 2014 Aug; 35(8):1788-97. PubMed ID: 24590894
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Inflammatory Cytokine Production in Human Monocytes by cGMP and IRAK3.
Nguyen TH; Axell A; Turek I; Wright B; Meehan-Andrews T; Irving HR
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269704
[TBL] [Abstract][Full Text] [Related]
8. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
[TBL] [Abstract][Full Text] [Related]
9. SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype.
Lombardi MS; Gilliéron C; Dietrich D; Gabay C
J Leukoc Biol; 2016 May; 99(5):711-21. PubMed ID: 26590148
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
11. IRAK3 Knockout and Wildtype THP-1 Monocytes as Models for Endotoxin Detection Assays and
Binte Mohamed Yakob Adil SS; Kabwe M; Cianciarulo C; Nguyen TH; Irving H; Tucci J
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894788
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.
Principe N; Aston WJ; Hope DE; Tilsed CM; Fisher SA; Boon L; Dick IM; Chin WL; McDonnell AM; Nowak AK; Lake RA; Chee J; Lesterhuis WJ
Front Immunol; 2022; 13():872295. PubMed ID: 35634282
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and meta-analyses of interleukin-1 receptor associated kinase 3 (IRAK3) action on inflammation in in vivo models for the study of sepsis.
Nguyen TH; Turek I; Meehan-Andrews T; Zacharias A; Irving HR
PLoS One; 2022; 17(2):e0263968. PubMed ID: 35167625
[TBL] [Abstract][Full Text] [Related]
14. IL-32γ potentiates tumor immunity in melanoma.
Gruber T; Kremenovic M; Sadozai H; Rombini N; Baeriswyl L; Maibach F; Modlin RL; Gilliet M; von Werdt D; Hunger RE; Seyed Jafari SM; Parisi G; Abril-Rodriguez G; Ribas A; Schenk M
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841222
[TBL] [Abstract][Full Text] [Related]
15. TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.
Standiford TJ; Kuick R; Bhan U; Chen J; Newstead M; Keshamouni VG
Oncogene; 2011 May; 30(21):2475-84. PubMed ID: 21278795
[TBL] [Abstract][Full Text] [Related]
16. Dimeric Structure of the Pseudokinase IRAK3 Suggests an Allosteric Mechanism for Negative Regulation.
Lange SM; Nelen MI; Cohen P; Kulathu Y
Structure; 2021 Mar; 29(3):238-251.e4. PubMed ID: 33238146
[TBL] [Abstract][Full Text] [Related]
17. At Least Two Genes Encode Many Variants of Irak3 in Rainbow Trout, but Neither the Full-Length Factor Nor Its Variants Interfere Directly With the TLR-Mediated Stimulation of Inflammation.
Rebl A; Rebl H; Verleih M; Haupt S; Köbis JM; Goldammer T; Seyfert HM
Front Immunol; 2019; 10():2246. PubMed ID: 31616422
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer.
Chen Y; Sun J; Luo Y; Liu J; Wang X; Feng R; Huang J; Du H; Li Q; Tan J; Ren G; Wang X; Li H
J Transl Med; 2022 Dec; 20(1):615. PubMed ID: 36564797
[TBL] [Abstract][Full Text] [Related]
19. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Hailemichael Y; Johnson DH; Abdel-Wahab N; Foo WC; Bentebibel SE; Daher M; Haymaker C; Wani K; Saberian C; Ogata D; Kim ST; Nurieva R; Lazar AJ; Abu-Sbeih H; Fa'ak F; Mathew A; Wang Y; Falohun A; Trinh V; Zobniw C; Spillson C; Burks JK; Awiwi M; Elsayes K; Soto LS; Melendez BD; Davies MA; Wargo J; Curry J; Yee C; Lizee G; Singh S; Sharma P; Allison JP; Hwu P; Ekmekcioglu S; Diab A
Cancer Cell; 2022 May; 40(5):509-523.e6. PubMed ID: 35537412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
